I-Afatinib Dimaleate Intermediate CAS 314771-76-1 Purity >99.0% (HPLC) Factory
I-Ruifu Chemical Supply Intermediates ye-Afatinib
I-Afatinib CAS 439081-18-2
I-Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
(I-Dimethylamino)i-acetaldehyde I-Diethyl Acetal CAS 3616-56-6
trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7
I-Diethylphosphonoacetic Acid CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4(1H)-one CAS 162012-69-3
I-7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-DiamineI-CAS 314771-76-1
(S)-N-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl)oxy)quinazolin-4-AmineI-CAS 314771-88-5
Igama Lekhemikhali | (S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine |
Omqondofana | I-N4-(3-Chloro-4-Fluorophenyl)-7-[[(3S)-Tetrahydro-3-Furanyl]oxy] -4,6-Quinazolinediamine;I-Afatinib Ukungcola B;I-Afatinib-des(4-Dimethylamino-2-en-1-oxo)butyl;I-Des(4-Dimethylamino-2-en-1-oxo)butyl Afatinib |
Inombolo ye-CAS | 314771-76-1 |
Inombolo yeCAT | I-RF-PI2028 |
Isimo Sesitoko | Esitokweni, Amandla Okukhiqiza 100MT/Ngonyaka |
I-Molecular Formula | I-C18H16ClFN4O2 |
Isisindo samangqamuzana | 374.8 |
Iphuzu elibilayo | 559.0±50.0℃ |
Ukuminyana | 1.473±0.060 g/cm3 |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Ephuzi Ekhanyayo ukuya Ephuzi |
Ukuhlonza | Isikhathi Sokugcinwa Kwenani Eliphakeme Eliyinhloko ku-HPLC Kufanele Sihambisane Nezinga |
Ukuhlanzeka / Indlela Yokuhlaziya | >99.0% (HPLC) |
Ukulahlekelwa Ekumisweni | <0.50% |
Izinsalela ekushiseni | <0.20% |
Ukungcola Okukodwa | <0.50% |
Ukungcola Okuphelele | <1.00% |
Izinsimbi Ezisindayo (njenge-Pb) | ≤20ppm |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Intermediate ye-Afatinib Dimaleate (CAS: 850140-73-7) |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine (CAS: 314771-76-1) iphakathi kwe-Afatinib Dimaleate (CAS: 850140-73-7).I-Afatinib iyisizukulwane sesibili esinamandla futhi esingahlehliki inhibitor ekabili ye-epidermal growth factor receptor (EGFR) kanye ne-human epidermal growth factor receptor 2 (HER2) tyrosine kinase, eyakhiwe ngu-Boehringer Ingelheim, eJalimane.Iyakwazi ukuvimbela ngendlela engenakuhlehliswa umsebenzi we-tyrosine kinase ngokubhekana nokusabela kukaMichael neqembu le-thiol le-cysteine indawo engu-797 ye-EGFR.Umsebenzi: 1. NjengeLapatinib neNeratinib, i-Afatinib iyi-protein kinase inhibitor ephinde ivimbele ngendlela engenakulungiseka i-epidermal growth factor receptor 2 (Her2) kanye ne-epidermal growth factor receptor (EGFR) kinases.2. I-Afatinib ayisebenzi kuphela ngokumelene nokuguqulwa kwe-EGFR okuqondiswe i-TKI yesizukulwane sokuqala njenge-erlotinib noma i-gefitinib, kodwa futhi ngokumelene nokuguqulwa okufana ne-T790M engazweli kulezi zindlela zokwelapha ezijwayelekile.Ngenxa yomsebenzi wayo owengeziwe ngokumelene ne-Her2, kuphenywa umdlavuza webele kanye neminye imidlavuza eqhutshwa yi-EGFR kanye ne-Her2.3. I-Afatinib iwumuthi wokwelapha womugqa wokuqala weziguli ezinezinhlobo ezihlukile ze-metastatic (EGFR mutation positive) engeyona encane i-cell lung carcinoma (NSCLC).Isebenza njenge-covalent inhibitor engenakuhlehliswa ye-receptor tyrosine kinases epidermal growth factor receptor (EGFR) kanye ne-erbB-2 (HER2).